Viewing Study NCT05296538



Ignite Creation Date: 2024-05-06 @ 5:24 PM
Last Modification Date: 2024-10-26 @ 2:28 PM
Study NCT ID: NCT05296538
Status: COMPLETED
Last Update Posted: 2024-03-06
First Post: 2022-02-11

Brief Title: The Mental Imagery for Suicidality in Students Trial MISST
Sponsor: Greater Manchester Mental Health NHS Foundation Trust
Organization: Greater Manchester Mental Health NHS Foundation Trust

Study Overview

Official Title: The Mental Imagery for Suicidality in Students Trial MISST A Feasibility Study
Status: COMPLETED
Status Verified Date: 2024-03
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: MISST
Brief Summary: In the UK suicide is the leading cause of death in young people and have increased in recent years Areas in the North of England appear particularly at risk University students represent one vulnerable group 42 of students contemplate suicide in any one-year period Suicidal thinking is an important indicator of distress and clinical need which predicts subsequent suicidal experiences and worse mental health It is therefore an important target for clinical treatment and early intervention However evidenced based interventions for targeting suicidal thinking in students are lacking

This project will evaluate the feasibility of a novel psychological intervention called the Broad Minded Affective Coping BMAC intervention The BMAC aims to increase peoples access to positive thoughts and emotions to help them to break out of cycles of negative mood and suicidal thinking It is targeted protocolised and deliverable by a range of professional groups Our existing co-development work with young people has suggested that it is acceptable and helpful to University students This randomised controlled feasibility trial of the BMAC intervention for suicidal thinking in university students Participants will be randomised to either a risk assessment and signposting plus the BMAC n 33 or risk assessment and signposting alone n 33 The study will assess outcomes at baseline and after eight weeks 16 weeks and 24 weeks The study will explore the safety feasibility and acceptability of delivering the intervention and trial procedures Embedded qualitative interviews with staff and participants and field notes will help us to understand the potential factors affecting acceptability and delivery of the BMAC intervention and conduct of the trial and the proposed underlying mechanisms of change The project will be a crucial step in evaluating the BMAC for suicidal students paving the way for a larger trial of clinical effectiveness
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None